文献速递肝病消化道出血消化内镜

肝硬化患者小肠静脉曲张:高容量肝移植中心的回顾性数据库研究与文献综述

Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

本研究通过回顾性数据库分析2008至2019年间71例肝硬化合并小肠静脉曲张(SIV)患者,其中18例发生出血,并与文献中76例出血性SIV病例比较。结果显示本院队列住院死亡率和总死亡率分别为22%和38%,高于文献病例的5.3%和18.4%(P=0.02和P=0.07)。约四分之一肝硬化SIV患者发生出血,需频繁二次干预且死亡率高,提示多学科管理的重要性。

要点

  • 肝硬化合并小肠静脉曲张患者中约四分之一发生出血,输血需求高。
  • 初始止血治疗包括药物、内镜、介入放射和手术,止血率分别为57%、56%、77%和87%。
  • 本院队列住院死亡率和总死亡率高于文献病例,需多学科管理和二线治疗。

核心结论

  • 肝硬化合并小肠静脉曲张患者中约四分之一发生出血,输血需求高,常需二次干预,死亡率高。

研究设计与样本

  • 回顾性数据库研究,使用2008至2019年账单代码和自然语言处理进行机构病历审查,纳入成人肝硬化经内镜、视频胶囊或影像学证实的小肠静脉曲张患者,排除非肝硬化性门脉高压和造口静脉曲张。
  • 共识别71例肝硬化合并小肠静脉曲张患者(18例出血),并通过文献检索汇总76例出血性小肠静脉曲张病例进行匹配比较。

主要发现

  • 本院队列71例中18例发生出血,文献汇总76例出血性小肠静脉曲张病例。
  • 两队列在年龄、性别、肝病病因和小肠静脉曲张位置上匹配,住院时间和输血需求相似。
  • 汇总初始治疗(例数,止血率):药物(7例,57%)、内镜(48例,56%)、介入放射(31例,77%)、手术(8例,87%)。
  • 本院队列住院死亡率和总死亡率分别为22%和38%,文献病例分别为5.3%和18.4%(P=0.02和P=0.07)。

临床怎么用

  • 对肝硬化合并小肠静脉曲张患者应警惕出血风险,及时评估输血需求。
  • 初始治疗止血率有限,需准备二线治疗方式并提倡多学科协作管理。

局限性

  • 回顾性数据库研究,可能存在编码和病历记录偏倚;文献病例对照非随机,存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Esophageal varices are a well-characterized sequela of portal hypertension; however, less is known about varices arising in ectopic locations. We aimed to describe bleeding small intestine varices (SIV) in patients with cirrhosis and compare characteristics and outcomes to published case reports. METHODS: We performed an institutional chart review using billing codes and natural language processing between 2008 and 2019. Inclusion criteria were adult patients with cirrhosis and SIV verified by endoscopy, video capsule, or imaging. Patients with noncirrhotic portal hypertension and stomal varices were excluded. We examined demographic and clinical factors, characteristics of SIV, bleeding, intervention, and outcomes in our series and collated data from published cases identified during a literature review. RESULTS: We identified 71 patients with cirrhosis and SIV (18 bled). The literature search yielded 76 cases with bleeding SIV. Our series and published cases were matched for age, sex, liver disease etiology, and SIV location. Length of stay and transfusion requirements were similar. Aggregate initial treatments (number, hemostasis rate) included medical (n = 7, 57%), endoscopic (n = 48, 56%), interventional radiology (n = 31, 77%), and surgery (n = 8, 87%). Hospital and overall mortality rates were higher in our series (22% and 38%) compared with the published cases (5.3% and 18.4%), respectively (P = 0.02 and P = 0.07). DISCUSSION: A quarter of patients with cirrhosis and SIV experience bleeding, with high transfusion requirements, frequent need for secondary interventions, and high mortality. These findings highlight the need for a multidisciplinary approach and second-line therapeutic modalities in the timely management of bleeding SIV in cirrhosis.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Jansson-Knodell CL, Calderon G, Weber R, et al. Small Intestine Varices in Cirrhosis at a High-Volume Liver Transplant Center: A Retrospective Database Study and Literature Review. Am J Gastroenterol. 2021. PMID: 33734116. doi:10.14309/ajg.0000000000001204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。